437
Views
32
CrossRef citations to date
0
Altmetric
Research Article

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

, , , , , , , & show all
Pages 830-835 | Received 03 Aug 2011, Accepted 10 Oct 2011, Published online: 06 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Charlotte Madsen, Trine Lindhardt Plesner, Hans Herluf Bentzen, Judit Jørgensen, Ida Blok Sillesen, Bodil M. Himmelstrup, Pär Josefsson, Torben Plesner, Tine Litske Bennedsen, Maja Ludvigsen & Francesco A. d’Amore. (2020) Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leukemia & Lymphoma 61:11, pages 2584-2594.
Read now
Mita Manna, Richard Lee-Ying, Gwynivere Davies, Colin Stewart, Danielle H. Oh, Anthea Peters & Douglas A. Stewart. (2019) Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world. Leukemia & Lymphoma 60:1, pages 133-141.
Read now
Jay Patrick Lopez & Tsiporah B Shore. (2016) Bendamustine and stem-cell mobilization: not so bad!. Leukemia & Lymphoma 57:5, pages 993-994.
Read now
Yngvild N. Blaker, Marianne B. Eide, Knut Liestøl, Grete F. Lauritzsen, Arne Kolstad, Alexander Fosså, Erlend B. Smeland & Harald Holte. (2014) High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era. Leukemia & Lymphoma 55:10, pages 2319-2327.
Read now

Articles from other publishers (27)

Colton Ladbury, Swetha Kambhampati, Tamer Othman, Claire Hao, Lu Chen, Jeffrey Wong, Thai Cao, Alex Herrera, Matthew Mei & Savita Dandapani. (2022) Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell Transplant. International Journal of Radiation Oncology*Biology*Physics 113:3, pages 594-601.
Crossref
John C. Reneau & Basem M. William. (2020) Autologous stem cell transplant in first remission for transformed indolent non‐Hodgkin lymphoma: additional data to guide practice. British Journal of Haematology 191:5, pages 663-665.
Crossref
Yucai Wang, Brian K. Link, Thomas E. Witzig, Matthew J. Maurer, Cristine Allmer, Rebecca L. King, Andrew L. Feldman, Thomas M. HabermannStephen M. AnsellSusan L. Slager, James R. Cerhan & Grzegorz S. Nowakowski. (2019) Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma. Blood 134:16, pages 1289-1297.
Crossref
Andrew D. ZelenetzLeo I. GordonJeremy S. AbramsonRanjana H. AdvaniNancy L. BartlettPaolo F. CaimiJulie E. ChangJulio C. ChavezBeth ChristianLuis E. FayadMartha J. GlennThomas M. HabermannNancy Lee HarrisFrancisco Hernandez-IlizaliturriMark S. KaminskiChristopher R. KelseyNadia KhanSusan KrivacicAnn S. LaCasceAmitkumar MehtaAuayporn NademaneeRachel RabinovitchNishitha ReddyErin ReidKenneth B. RobertsStephen D. SmithErin D. SnyderLode J. SwinnenJulie M. Vose, Mary A. DwyerHema Sundar. (2019) NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. Journal of the National Comprehensive Cancer Network 17:6, pages 650-661.
Crossref
Carla Minoia, Emanuele Zucca & Annarita Conconi. (2018) Novel acquisitions on biology and management of transformed follicular lymphoma. Hematological Oncology 36:4, pages 617-623.
Crossref
Marc Sorigue, Olga Garcia, Maria Joao Baptista, Juan-Manuel Sancho, Gustavo Tapia, José Luis Mate, Evarist Feliu, José-Tomás Navarro & Josep-Maria Ribera. (2017) Pronóstico similar de los linfomas transformados y los linfomas difusos de células B grandes de novo en pacientes tratados con inmunoquimioterapia. Medicina Clínica 148:6, pages 243-249.
Crossref
Marc Sorigue, Olga Garcia, Maria Joao Baptista, Juan-Manuel Sancho, Gustavo Tapia, José Luis Mate, Evarist Feliu, José-Tomás Navarro & Josep-Maria Ribera. (2017) Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy. Medicina Clínica (English Edition) 148:6, pages 243-249.
Crossref
Avichai Shimoni. (2017) The role of stem-cell transplantation in the treatment of marginal zone lymphoma. Best Practice & Research Clinical Haematology 30:1-2, pages 166-171.
Crossref
Alina M Bischin, Russell Dorer & David M Aboulafia. (2017) Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Clinical Medicine Insights: Blood Disorders 10, pages 1179545X1769254.
Crossref
Robin M. Reid, Andrea Baran, Jonathan W. Friedberg, Gordon L. PhillipsIIII, Jane L. Liesveld, Michael W. Becker, Lucy Wedow, Paul M. Barr & Laurie A. Milner. (2016) Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective. Cancer Medicine 5:11, pages 3059-3067.
Crossref
Patrick M. Reagan, Andrea Baran, Jennifer L. Kelly, Paul M. Barr, Carla Casulo, Vaseem U. Chengazi & Jonathan W. Friedberg. (2016) Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 16:6, pages 322-328.e2.
Crossref
Leslie L. Popplewell & Ginna G. Laport. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 692 705 .
Nina D. Wagner-JohnstonBrian K. LinkMichelle ByrtekKeith L. DawsonJohn HainsworthChristopher R. Flowers, Jonathan W. Friedberg & Nancy L. Bartlett. (2015) Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood 126:7, pages 851-857.
Crossref
John Kuruvilla, David A. MacDonaldC. Tom KouroukisMatthew CheungHarold J. OlneyA. Robert TurnerPeter AnglinMatthew SeftelWalid Sabry IsmailStefano LuminariStephen CoubanTara BaetzRalph M. Meyer, Annette E. Hay, Lois Shepherd, Marina S. Djurfeldt, Sameer Alamoudi, Bingshu E. Chen & Michael Crump. (2015) Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12. Blood 126:6, pages 733-738.
Crossref
K. Lerch, A. H. Meyer, A. Stroux, C. Hirt, U. Keller, A. Viardot, R. Marks, S. Schreiber, A. Pezzutto & C. W. Scholz. (2015) Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis. Annals of Hematology 94:6, pages 981-988.
Crossref
C. Madsen, M.B. Pedersen, M.Ø. Vase, K. Bendix, M.B. Møller, P. Johansen, B.A. Jensen, P. Jensen, L. Munksgaard, P.D. Brown, E.K. Segel & F.A. d'Amore. (2015) Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Annals of Oncology 26:2, pages 393-399.
Crossref
Carla Casulo, W. Richard Burack & Jonathan W. Friedberg. (2015) Transformed follicular non-Hodgkin lymphoma. Blood 125:1, pages 40-47.
Crossref
Matthew Mei, Marielle J. Wondergem, Joycelynne M. Palmer, Avichai Shimoni, Justin Hasenkamp, Ni-Chun Tsai, Jennifer Simpson, Auayporn Nademanee, Andrew Raubitschek, Stephen J. Forman & Amrita Y. Krishnan. (2014) Autologous Transplantation for Transformed Non-Hodgkin Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen. Biology of Blood and Marrow Transplantation 20:12, pages 2072-2075.
Crossref
Diego Villa, Anupkumar George, John F. Seymour, Cynthia L. Toze, Michael Crump, Christina Lee, Rena Buckstein, Douglas A. Stewart, David MacDonald, Ronan Foley, Anargyros Xenocostas, Mitchell Sabloff, Neil Chua, Felix Couture, Jean F. Larouche, Sandra Cohen, Kerry J. Savage, Joseph M. Connors, Tony Panzarella, Dennis A. Carney, Michael Dickinson & John Kuruvilla. (2014) Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma. Biology of Blood and Marrow Transplantation 20:11, pages 1813-1818.
Crossref
Stephane Doucet & Jane N. Winter. 2014. Cancer Consult: Expertise for Clinical Practice. Cancer Consult: Expertise for Clinical Practice 295 303 .
Baldeep Wirk, Timothy S. Fenske, Mehdi Hamadani, Mei-Jie Zhang, Zhen-Huan Hu, Görgün Akpek, Mahmoud D. Aljurf, Philippe Armand, Ernesto Ayala, Veronika Bachanova, Brian Bolwell, Mitchell S. Cairo, Amanda Cashen, Yi-Bin Chen, Luciano J. Costa, Shatha Farhan, César O. Freytes, James L. Gajewski, John Gibson, Gregory A. Hale, Leona A. Holmberg, Jack W. Hsu, David J. Inwards, Rummurti T. Kamble, Dipnarine Maharaj, Richard T. Maziarz, Reinhold Munker, Rajneesh Nath, Nishitha M. Reddy, Craig B. Reeder, David A. Rizzieri, Craig S. Sauter, Bipin N. Savani, Harry C. Schouten, Anna Sureda, Julie M. Vose, Edmund K. Waller, Peter H. Wiernik, Robert Peter Gale, Linda J. Burns & Wael Saber. (2014) Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma. Biology of Blood and Marrow Transplantation 20:7, pages 951-959.
Crossref
Chan Y. Cheah, Michael Dickinson, Michael S. Hofman, Anupkumar George, David S. Ritchie, H. Miles Prince, David Westerman, Simon J. Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E. Herbert, Dennis A. Carney, Constantine Tam & John F. Seymour. (2014) Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy. Annals of Hematology 93:7, pages 1193-1200.
Crossref
Antonino Carbone & Anas YounesJonathan FriedbergShahrukh Hashmi. 2013. Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies. Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies 182 195 .
D. Villa, M. Crump, A. Keating, T. Panzarella, B. Feng & J. Kuruvilla. (2013) Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation. Annals of Oncology 24:6, pages 1603-1609.
Crossref
Diego VillaMichael CrumpTony PanzarellaKerry J. SavageCynthia L. TozeDouglas A. StewartDavid A. MacDonaldRena BucksteinChristina LeeMohsen AlzahraniMorel RubingerRonan FoleyAnargyros XenocostasMitchell SabloffAlexandra MuccilliNeil ChuaFelix CoutureJean-François LaroucheSandra CohenJoseph M. ConnorsKimberley AmblerAbdulwahab Al-TourahKhaled M. RamadanJohn Kuruvilla. (2013) Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group. Journal of Clinical Oncology 31:9, pages 1164-1171.
Crossref
Philippe Armand, Sarah Welch, Haesook T. Kim, Ann S. LaCasce, Eric D. Jacobsen, Matthew S. Davids, Caron Jacobson, David C. Fisher, Jennifer R. Brown, Erin Coughlin, Arnold S. Freedman & Yi‐Bin Chen. (2012) Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era . British Journal of Haematology 160:5, pages 608-617.
Crossref
Eric Wong & Michael Dickinson. (2012) Transformation in Follicular Lymphoma: Biology, Prognosis, and Therapeutic Options. Current Oncology Reports 14:5, pages 424-432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.